FollowTheFilings

Managers Activity Compare Newest

Investment

BRIDGEBIO PHARMA INC

Historical 13F holders

CUSIP: 10806XAD4
Type: Debt
Class: NOTE 2.250% 2/0

Period	13F filings
2025 Q4	3
2025 Q3	3
2025 Q2	4
2025 Q1	4
2024 Q4	4
2024 Q3	3

FollowTheFilings · Institutional 13F data room

All managers Activity Compare Newest filings X

Data is sourced from SEC EDGAR as filed. The SEC does not guarantee accuracy or completeness. Holdings exclude shorts and many derivatives; values are as of the report date.